Genprex, Inc.
GNPX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595248
No open-market purchases or sales by Genprex, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $154.9K in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Genprex, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 45
- +3 vs. Q3 2022
- Shares held
- 4.04M
- −429.7K (−9.6%) vs. Q3 2022
- Total value
- $5.84M
- −$451.9K (−7.2%) vs. Q3 2022
- New holders
- 7
- 7 more added
- Sold out
- 4
- 14 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GNPX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 27 | $154.9K |
| Q1 2026 | 27 | $169.0K |
| Q4 2025 | 22 | $13.0K |
| Q3 2025 | 21 | $229.5K |
| Q2 2025 | 28 | $152.9K |
| Q1 2025 | 24 | $93.5K |
| Q4 2024 | 22 | $247.0K |
| Q3 2024 | 21 | $79.7K |
| Q2 2024 | 15 | $510.3K |
| Q1 2024 | 17 | $426.0K |
| Q4 2023 | 36 | $1.16M |
| Q3 2023 | 39 | $2.61M |
| Q2 2023 | 38 | $3.64M |
| Q1 2023 | 39 | $5.42M |
| Q4 2022 | 45 | $5.84M |
| Q3 2022 | 43 | $6.29M |
| Q2 2022 | 42 | $6.11M |
| Q1 2022 | 50 | $10.8M |
| Q4 2021 | 47 | $9.78M |
| Q3 2021 | 49 | $15.8M |
| Q2 2021 | 59 | $19.5M |
| Q1 2021 | 72 | $35.4M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Genprex, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 1,826,600 | $2.65M | 0.00% | +1,043+0.1% | Added |
| BlackRock Inc. | 564,628 | $818.7K | 0.00% | +1,640+0.3% | Added |
| Geode Capital Management, LLC | 432,137 | $626.0K | 0.00% | −8,520−1.9% | Reduced |
| UBS Group AG | 160,546 | $232.8K | 0.00% | −119,788−42.7% | Reduced |
| State Street Corp | 129,739 | $188.1K | 0.00% | 00.0% | Unchanged |
| Cypress Capital, LLC | 100,000 | $145.0K | 0.05% | 00.0% | Unchanged |
| Verus Capital Partners, LLC | 88,500 | $128.3K | 0.02% | −2,000−2.2% | Reduced |
| Northern Trust Corp | 86,430 | $125.3K | 0.00% | +11,029+14.6% | Added |
| Group One Trading, L.P. | 60,354 | $87.5K | 0.00% | −79,668−56.9% | Reduced |
| Silvercrest Asset Management Group LLC | 56,000 | $81.2K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 54,900 | $80.0K | 0.00% | −18,656−25.4% | Reduced |
| IHT Wealth Management, LLC | 52,375 | $75.9K | 0.00% | 00.0% | Unchanged |
| Staley Capital Advisers Inc | 50,000 | $72.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 35,688 | $51.7K | 0.00% | +21,508+151.7% | Added |
| StoneX Group Inc. | 35,150 | $51.0K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 31,569 | $46.0K | 0.00% | −112,201−78.0% | Reduced |
| Charles Schwab Investment Management Inc | 29,742 | $43.1K | 0.00% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 25,600 | $37.0K | 0.00% | −41,900−62.1% | Reduced |
| Dimensional Fund Advisors LP | 22,644 | $33.0K | 0.00% | 00.0% | Unchanged |
| TCG Advisory Services, LLC | 21,000 | $30.4K | 0.01% | +1,000+5.0% | Added |
| Per Stirling Capital Management, LLC. | 18,162 | $26.3K | 0.00% | +18,162 | New |
| Bank of New York Mellon Corp | 17,569 | $25.5K | 0.00% | 00.0% | Unchanged |
| TCWP LLC | 17,500 | $25.4K | 0.01% | +17,500 | New |
| CCG Wealth Management, LLC | 15,100 | $21.9K | 0.01% | +15,100 | New |
| Belvedere Trading LLC | 13,200 | $19.1K | 0.01% | +13,200 | New |
| Morgan Stanley | 12,910 | $18.7K | 0.00% | +1,590+14.0% | Added |
| Pekin Hardy Strauss, Inc. | 12,578 | $18.2K | 0.00% | 00.0% | Unchanged |
| David Loasby | 10,000 | $13.5K | 0.00% | −5,000−33.3% | Reduced |
| Meeder Asset Management Inc | 9,174 | $13.3K | 0.00% | −1,467−13.8% | Reduced |
| Advisor Group Holdings, Inc. | 9,262 | $13.3K | 0.00% | +200+2.2% | Added |
| Tower Research Capital LLC (TRC) | 8,013 | $12.0K | 0.00% | −12,973−61.8% | Reduced |
| Simplex Trading, LLC | 7,991 | $11.0K | 0.00% | −14,766−64.9% | Reduced |
| Bank of America Corp | 5,112 | $7.41K | 0.00% | −12,986−71.8% | Reduced |
| Royal Bank of Canada | 2,500 | $4.00K | 0.00% | −906−26.6% | Reduced |
| High Net Worth Advisory Group LLC | 1,000 | $1.45K | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 850 | $1.22K | 0.00% | 00.0% | Unchanged |
| VitalStone Financial, LLC | 400 | $1.00K | 0.00% | +400 | New |
| Burleson & Company, LLC | 400 | $580 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 327 | $474 | 0.00% | −1,191−78.5% | Reduced |
| TCI Wealth Advisors, Inc. | 300 | $435 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 73 | $106 | 0.00% | 00.0% | Unchanged |
| GWM Advisors LLC | 5,000 | $7 | 0.00% | +5,000 | New |
| JPMorgan Chase & Co | 177 | $0 | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 4,000 | – | – | 00.0% | Unchanged |
| Sofos Investments, Inc. | 1 | – | – | +1 | New |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −58,832−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −19,927−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −13,949−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | 0 | $0 | 0.00% | −12,301−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |